As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
COVID-19 and impact on peer review
-
-
A quasi-randomized clinical trial: virtual reality versus proprioceptive neuromuscular facilitation for postmastectomy lymphedema
-
Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation
-
Inflammatory myofibroblastic tumor of maxillary sinus successfully treated with radiotherapy and corticosteroid: report of a rare case
-
Report of two rare cases of adrenal incidentalomas with different origins: revisiting pathological and radiological findings with a short review of the literature
-
Hepatocellular Carcinoma (HCC) in Egypt: A comprehensive overview
-
Primary desmoplastic small-round-cell tumor of the ovary
-
Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival
-
Vulvar cancer: surgical management and survival trends in a low resource setting
-
Selective cytotoxic effect of Plantago lanceolata L. against breast cancer cells
About the Editor
Nadia M. Mokhtar, PhD.
Professor of Pathology, National Cancer Institute, Cairo University.
Aims and scope
As the official publication of the National Cancer Institute, Cairo University, the Journal of the Egyptian National Cancer Institute (JENCI) is an open access peer-reviewed journal that publishes on the latest innovations in oncology and thereby, providing academics and clinicians a leading research platform. JENCI welcomes submissions pertaining to all fields of basic, applied and clinical cancer research. Main topics of interest include: local and systemic anticancer therapy (with specific interest on applied cancer research from developing countries); experimental oncology; early cancer detection; randomized trials (including negatives ones); and key emerging fields of personalized medicine, such as molecular pathology, bioinformatics, and biotechnologies.
About the Society
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Cairo University, accomplishing high quality research in its respected field.
Official journal of
-
Journal of the Egyptian National Cancer Institute is the official journal of the National Cancer Institute, Egypt.
Citation Impact
0.94 - CiteScore
0.541 - SNIP (Source-Normalized Impact per Paper)
0.334 - SJR (SCImago Journal Rank)
- ISSN: 2589-0409 (electronic)
